Epidermal Cell-Polymorphonuclear Leukocyte Cooperation in the Formation of Leukotriene B4 by Transcellular Biosynthesis

  • L. Vila
  • N. Godessart
  • J. Sola
Part of the Developments in Oncology book series (DION, volume 71)


Since 1974 (1) there have been numerous reports in the literature showing the presence of large amounts of eicosanoids in psoriatic lesions. The metabolic pathways of arachidonic acid (AA) in freshly isolated human epidermal cells (EC) are still controversial (2–4). Although it has been reported that human EC can synthesize leukotriene B4 (LTB4) from AA (4), the actual cellular origin of LTB4 found in psoriatic lesions has not been definitively established yet. Infiltration of polymorphonuclear leukocytes (PMN) is one of the earliest events in the pathogenesis of psoriatic lesions and their accumulation can precede the appearance of the characteristic epidermal changes (5, 6). The conversion of PMN-produced leukotriene A4 (LTA4) to LTB4 by EC could contribute to increase the amount of LTB4 present in lesions of psoriasis or other inflammatory dermatoses. In this study, we explore the capability of EC to synthesize LTB4 from AA and/or transform PMN-derived LTA4 into LTB4.


Arachidonic Acid Epidermal Cell Polymorphonuclear Leukocyte Cold Methanol Psoriatic Lesion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hammarstrom S, Hamberg M, Samuelsson B, Duell EA, Stawiski M, Voorhees JJ Proc Natl Acad Sci USA 72:5130–5134, 1975PubMedCrossRefGoogle Scholar
  2. 2.
    Vila L, Godessart N, Lagunas C, Sola J, Puig L, De Moragas JM. Med Cut Iber Lat Am 17:332–337, 1989Google Scholar
  3. 3.
    Holtzman MJ, Turk J, Pentland A. J din invest 84:1446–1453, 1989Google Scholar
  4. 4.
    Rosenbach T, Czernielewski J, Hecker M, Czarnelzki B. J Invest Dermatol 95:104–105, 1990PubMedCrossRefGoogle Scholar
  5. 5.
    Pinkus H, Mehergan AH. J Invest Dermatol 46:109–116, 1966PubMedGoogle Scholar
  6. 6.
    Fogh K, Herlin T, Kragballe K. J Invest Dermatol 92:837–841, 1989PubMedCrossRefGoogle Scholar
  7. 7.
    Liu SC, Karasek M. J Invest Dermatol 71:157–162, 1978PubMedCrossRefGoogle Scholar
  8. 8.
    Sola J, Vila L, Puig L, de Moragas JM. Arch Dermatol Res 283:77–80 1991PubMedCrossRefGoogle Scholar
  9. 9.
    Maycock AL, Anderson MS, De Sousa DM, Kuehl A. J Biol Chem 257:13911–13914, 1982PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • L. Vila
    • 1
  • N. Godessart
    • 1
  • J. Sola
    • 1
  1. 1.Inflammation and Cell Proliferation Mediators Dpt. Biomedical Research InstituteFISP. Hospital de la Santa Creu i Sant PauBarcelonaSpain

Personalised recommendations